Your institution may have access to this item. Find your institution then sign in to continue.
Title
Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study.
Authors
Belch, J J; Capell, H A; Cooke, E D; Kirby, J D; Lau, C S; Madhok, R; Murphy, E; Steinberg, M
Abstract
To compare the efficacy, tolerance and safety of 50-150 micrograms orally administered iloprost given twice a day versus placebo in patients with Raynaud's syndrome.
Publication
Annals of the rheumatic diseases, 1995, Vol 54, Issue 3, p197